Eli Lilly xStock is projected to rise to $1,422.35 by 2027, a +16% move from its current price of $1,221.84. LLYX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 26 | $1,189.72 | $1,223.72 | $1,258.70 | +0.15% |
| Jul 27 | $1,177.72 | $1,225.60 | $1,275.44 | +0.31% |
| Jul 28 | $1,169.01 | $1,227.49 | $1,288.89 | +0.46% |
| Jul 29 | $1,162.00 | $1,229.38 | $1,300.66 | +0.62% |
| Jul 30 | $1,156.08 | $1,231.27 | $1,311.36 | +0.77% |
| Jul 31 | $1,150.91 | $1,233.17 | $1,321.30 | +0.93% |
| Aug 1 | $1,146.33 | $1,235.07 | $1,330.68 | +1.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1,146.33 | $1,235.07 | $1,330.68 | +1.08% |
| Week 2 | $1,123.50 | $1,248.44 | $1,387.27 | +2.18% |
| Week 3 | $1,109.06 | $1,261.95 | $1,435.92 | +3.28% |
| Week 4 | $1,098.89 | $1,275.61 | $1,480.75 | +4.40% |
| Week 5 | $1,091.41 | $1,289.42 | $1,523.36 | +5.53% |
| Week 6 | $1,085.80 | $1,303.38 | $1,564.55 | +6.67% |
| Week 7 | $1,081.61 | $1,317.49 | $1,604.80 | +7.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Eli Lilly xStock (LLYX) is a tokenized stock within the xStocks ecosystem. xStocks are tokenized stocks backed 1:1 by the underlying assets, composable with DeFi protocols, compliant with EU regulations, accessible to non-US users, and provide a legal claim to the value of the stock. xStocks enable easy access to 57 US Stocks and ETFs to regular users through top centralized and decentralized exchanges, and can be integrated with other DeFi protocols like any other token.
Eli Lilly xStock represents exposure to Eli Lilly within this tokenized stock framework, offering a digital construct that follows the xStock model. It sits among tokenized assets designed to mirror traditional equities while being accessible and composable across DeFi environments."
LLYX is currently priced at $1,221.84 with a market cap of $587.73K, and it ranks 3353 by market capitalization. The asset’s all-time high is $1,264.36 and its all-time low is $624.79, illustrating a history of price movement within a broad range.
The 30-day price range spans from $1,047.07 to $1,425.78, providing context for near-term variability. The technical picture shows a bullish tilt, with RSI(14) at 60, and key moving averages at $1,108.20 (SMA50) and $1,029.72 (SMA200). Support sits at $1,065.14 and resistance at $1,256.70.
Forecasts imply a path of growth with a current match to the present price in 2026 (avg $1,221.84). The model projects higher averages in later years, including $4,610.57 in 2030 and $62,142.38 in 2040, with $205,738.54 in 2050. Expected ROIs rise over time, reaching 277.4% in 2030, 4986% in 2040, and 16738.4% in 2050, all in bullish territory for long-horizon horizons.
A major floor 30.0% below — a decisive break under it would weaken the trend.
The nearest floor, 12.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 12.4% above — clearing it would confirm fresh momentum.
Key LLYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LLYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1,235.99 | Sell | $1,219.46 | Buy |
| MA 10 | $1,176.55 | Buy | $1,192.73 | Buy |
| MA 20 | $1,154.99 | Buy | $1,163.68 | Buy |
| MA 50 | $1,105.38 | Buy | $1,109.56 | Buy |
| MA 100 | $1,018.57 | Buy | $1,062.06 | Buy |
| MA 200 | $1,029.02 | Buy | $1,015.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.93 | Neutral |
| Stoch RSI (14) | 66.17 | Neutral |
| CCI (20) | 102.85 | Buy |
| Williams %R (14) | -21.31 | Info |
| MACD (12,26,9) | 10.22 | Buy |
| ROC (12) | 10.24 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 78.69 | Neutral |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 95.84 | Buy |
| Ultimate (7,14,28) | 70.21 | Sell |
| Momentum (10) | 128.77 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1273.83 | Sell |
| ADX (14) | 22.26 | Buy |
| ATR (14) | 20.10 | Info |
The near-term technical picture is bullish, with RSI(14) at 60 signaling constructive momentum.
The market is trading above the 50-day and 200-day moving averages, with SMA50 at $1,108.20 and SMA200 at $1,029.72, suggesting a positive intra-range bias.
Support is noted at $1,065.14 and resistance at $1,256.70, framing a near-term trading area. Over the last 30 days the price traded between $1,047.07 and $1,425.78, highlighting a blend of volatility and upside potential.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $855.88 | $1,221.84 | $1,782.82 | 0% | Neutral | |
| $1,119.48 | $1,422.35 | $1,919.58 | +16% | Neutral | |
| $1,438.65 | $1,885.71 | $2,648.96 | +54% | Bullish | |
| $3,923.77 | $5,278.50 | $7,651.12 | +332% | Bullish | |
| $3,349.22 | $4,610.57 | $6,861.36 | +277% | Bullish | |
| $3,413.99 | $4,799.71 | $7,308.84 | +293% | Bullish | |
| $8,574.44 | $12,294.11 | $19,110.17 | +906% | Bullish | |
| $9,322.75 | $13,616.57 | $21,563.61 | +10.1x | Bullish | |
| $8,474.39 | $12,597.44 | $20,293.92 | +931% | Bullish | |
| $10,719.24 | $16,206.01 | $26,524.66 | +12.3x | Bullish | |
| $38,051.43 | $62,142.38 | $108,685.01 | +49.9x | Bullish | |
| $110,088.89 | $205,738.54 | $396,150.73 | +167.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $855.88 | $1,221.84 | $1,467.76 | +0.00% |
| August 2026 | $1,122.33 | $1,332.70 | $1,630.79 | +9.07% |
| September 2026 | $1,175.37 | $1,405.84 | $1,739.84 | +5.49% |
| October 2026 | $1,086.82 | $1,308.24 | $1,634.92 | -6.94% |
| November 2026 | $1,057.42 | $1,279.83 | $1,612.66 | -2.17% |
| December 2026 | $1,154.15 | $1,404.09 | $1,782.82 | +9.71% |
Click any year to see its month-by-month LLYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The LLYX price prediction for 2026 points to an average of $1,221.84 (low $855.88, high $1,782.82) — a potential gain of 0% on today's $1,221.84. Price action looks broadly range-bound.
In 2027, LLYX is projected to trade between $1,119.48 and $1,919.58, averaging $1,422.35 — a potential gain of +16% from today's $1,221.84. That is up +16% on the projected 2026 average. A consolidation phase looks the most probable path here.
Eli Lilly xStock's 2028 outlook centres on $1,885.71, within a $1,438.65 to $2,648.96 range. That is up +33% on the projected 2027 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2029, LLYX could reach as high as $7,651.12, with a base case around $5,278.50 and support toward $3,923.77 — roughly +332% from $1,221.84. Buyers look set to stay in control over this stretch.
Expect LLYX to range from $3,349.22 to $6,861.36 through 2030. The $4,610.57 average target implies a +277% move from current prices. That is -13% versus the projected 2029 average. Momentum favours further upside here.
The LLYX price prediction for 2031 points to an average of $4,799.71 (low $3,413.99, high $7,308.84) — a potential gain of +293% on today's $1,221.84. Buyers look set to stay in control over this stretch.
In 2032, LLYX is projected to trade between $8,574.44 and $19,110.17, averaging $12,294.11 — a potential gain of +906% from today's $1,221.84. That is up +156% on the projected 2031 average. Momentum favours further upside here.
Eli Lilly xStock's 2033 outlook centres on $13,616.57, within a $9,322.75 to $21,563.61 range. That is up +11% on the projected 2032 average. That marks a +10.1x change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, LLYX could reach as high as $20,293.92, with a base case around $12,597.44 and support toward $8,474.39 — roughly +931% from $1,221.84. Momentum favours further upside here.
Expect LLYX to range from $10,719.24 to $26,524.66 through 2035. The $16,206.01 average target implies a +12.3x move from current prices. That is up +29% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The LLYX price prediction for 2040 points to an average of $62,142.38 (low $38,051.43, high $108,685.01) — a potential gain of +49.9x on today's $1,221.84. Momentum favours further upside here.
In 2050, LLYX is projected to trade between $110,088.89 and $396,150.73, averaging $205,738.54 — a potential gain of +167.4x from today's $1,221.84. That is up +231% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in LLYX today (≈ 0.818438 LLYX) could be worth
$168,384.19
+$167,384.19 (+16738%) by 2050 · US Dollar
Based on the average projected LLYX price of $205,738.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LLYXwould be worth at today's price.
$1,000 invested in LLYX on Jul 29, 2025 (≈ 1.311162 LLYX) would be worth
$1,602.03
+$602.03 (+60.2%) today · 1.60× · US Dollar
Based on a LLYX entry price of $762.68 vs. today's $1,221.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1,125.22 | $1,085.87 | +8.6% |
| 1 month ago | $1,080.95 | $1,130.34 | +13.0% |
| 3 months ago | $955.92 | $1,278.18 | +27.8% |
| 6 months ago | $1,075.02 | $1,136.57 | +13.7% |
| All time ago | $762.68 | $1,602.03 | +60.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LLYX forecast.
Our base-case forecast reaches $2,400.00 around 2029.
Implied market cap at $2,400.00: $1.15M
The multi-year outlook shows significant upside potential in later years. In 2026 the avg price is $1,221.84 with a 0 ROI, followed by a 2027 avg of $1,422.35 and a 16.4% ROI.
From 2028 onward the forecast accelerates, with 2028 avg $1,885.71 and 54.3% ROI, then 2029 avg $5,278.50 and 332% ROI. By 2030 the avg is $4,610.57 and 277.4% ROI, and by 2031 the avg is $4,799.71 with 292.8% ROI.
The forecast escalates further to 2032 avg $12,294.11 (906.2% ROI), 2033 avg $13,616.57 (1014.4% ROI), 2034 avg $12,597.44 (931% ROI), and 2035 avg $16,206.01 (1226.4% ROI). By 2040 the avg price is $62,142.38 with 4986% ROI, and by 2050 the avg price reaches $205,738.54 with 16738.4% ROI. These figures are estimates and not guarantees; actual results can differ.
Tap a question to reveal the answer.
2030 avg $4,610.57 with a min of $3,349.22 and a max of $6,861.36; ROI 277.4%; sentiment BULLISH.
The forecast shows growing averages across multiple years, with positive ROIs such as 16.4% in 2027, 54.3% in 2028, 332% in 2029, and 277.4% in 2030, culminating in substantial upside by 2040 (ROI 4986) and 2050 (ROI 16738.4%). These are estimates, not guarantees, and should be considered with relevant risks.
Yes, the max forecast values include 2027 max $1,919.58 and 2028 max $2,648.96, indicating potential to surpass $2,000 within the forecast horizon, particularly by 2028.
Current price is $1,221.84 and the all-time high is $1,264.36.
2040 avg $62,142.38 with max $108,685.01 and min $38,051.43 (ROI 4986); 2050 avg $205,738.54 with max $396,150.73 and min $110,088.89 (ROI 16738.4).
Eli Lilly xStock Community Discussion
0Share your Eli Lilly xStock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.